DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells.
Saved in:
| Title: | DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells. |
|---|---|
| Authors: | Mangili F; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy., Esposito E; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy., Treppiedi D; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy., Catalano R; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy., Marra G; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy., Di Muro G; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy., Barbieri AM; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy., Locatelli M; Neurosurgery Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy., Lania AG; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.; Endocrinology and Diabetology Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Humanitas Research Hospital, Rozzano, Italy., Mangone A; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.; Endocrinology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Spada A; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy., Arosio M; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.; Endocrinology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Peverelli E; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy., Mantovani G; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.; Endocrinology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. |
| Source: | Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Jun 03; Vol. 13, pp. 867822. Date of Electronic Publication: 2022 Jun 03 (Print Publication: 2022). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-2392 |
|---|---|
| DOI: | 10.3389/fendo.2022.867822 |
